Application

18506164 · 7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof

Filed 2023-11-10 · Granted · Patent 12679834 (2026-07-14) The official file ↗The patent and its PDF ↗ · Art unit 1627 · Examiner Jackson J Hernandez Typical · CPC C07D 413/14 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

13.3 mo

to disposition 32.1 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.